The use of mucoadhesive polymers in ocular drug delivery.
暂无分享,去创建一个
[1] V. Londhe,et al. Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery. , 1999, International journal of pharmaceutics.
[2] A. Albertsson,et al. Preparation and characterisation of poly(adipic anhydride) microspheres for ocular drug delivery , 1996 .
[3] C. Lehr,et al. Lectin-mediated drug delivery: the second generation of bioadhesives. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[4] B. Munoz,et al. Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. , 1997, Ophthalmology.
[5] N A Peppas,et al. Surface modifications and molecular imprinting of polymers in medical and pharmaceutical applications. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[6] L. Balant,et al. Ocular Availability of Gentamicin in Small Animals After Topical Administration of a Conventional Eye Drop Solution and a Novel Long Acting Bioadhesive Ophthalmic Drug Insert , 1995, Pharmaceutical Research.
[7] A. Rozier,et al. Bioadhesion: The effect of polyacrylic acid on the ocular bioavailability of timolol , 1992 .
[8] Andreas Zimmer,et al. Microspheres and nanoparticles used in ocular delivery systems , 1995 .
[9] G. Novack,et al. Ocular safety of INS365 ophthalmic solution: a P2Y(2) agonist in healthy subjects. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[10] V. H. Lee,et al. Relative effectiveness of prodrug and viscous solution approaches in maximizing the ratio of ocular to systemic absorption of topically applied timolol. , 1988, Experimental eye research.
[11] L. Salminen. Review: systemic absorption of topically applied ocular drugs in humans. , 1990, Journal of ocular pharmacology.
[12] D. Monti,et al. Evaluation of high- and low-molecular-weight fractions of sodium hyaluronate and an ionic complex as adjuvants for topical ophthalmic vehicles containing pilocarpine , 1991 .
[13] A. Bernkop‐Schnürch,et al. Thiolated polymers: self-crosslinking properties of thiolated 450 kDa poly(acrylic acid) and their influence on mucoadhesion. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[14] P. Russo,et al. Design of poly-ε-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery , 2002 .
[15] R M Hill,et al. The thickness of the human precorneal tear film: evidence from reflection spectra. , 2000, Investigative ophthalmology & visual science.
[16] S. Garg,et al. Bioadhesive microspheres as a controlled drug delivery system. , 2003, International journal of pharmaceutics.
[17] O. Camber,et al. Sodium hyaluronate as an ophthalmic vehicle: some factors governing its effect on the ocular absorption of pilocarpine. , 1989, Current eye research.
[18] A. Bernkop‐Schnürch,et al. Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[19] R. Dana,et al. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjögren syndrome. , 2002, Investigative ophthalmology & visual science.
[20] P. Versura,et al. Scanning electron microscopy of normal human corneal epithelium obtained by scraping‐off in vivo , 1985, Acta ophthalmologica.
[21] S. Kawakami,et al. One-side-coated insert as a unique ophthalmic drug delivery system. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[22] A. Joshi,et al. A novel method to evaluate residence time in humans using a nonpenetrating fluorescent tracer. , 2002, Investigative ophthalmology & visual science.
[23] A. Ludwig,et al. Evaluation of polysaccharides intended for ophthalmic use in ocular dosage forms. , 1995, Farmaco.
[24] R. Farris,et al. Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca. , 1988, Archives of ophthalmology.
[25] P. Ding,et al. Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[26] S. Tseng,et al. Paracellular permeability of corneal and conjunctival epithelia. , 1989, Investigative ophthalmology & visual science.
[27] P. Couvreur,et al. Liposomes Dispersed Within a Thermosensitive Gel: A New Dosage Form for Ocular Delivery of Oligonucleotides , 1998, Pharmaceutical Research.
[28] V. Dodane,et al. Effect of chitosan on epithelial permeability and structure. , 1999, International journal of pharmaceutics.
[29] D. Monti,et al. Mucoadhesive ophthalmic vehicles: evaluation of polymeric low-viscosity formulations. , 1994, Journal of ocular pharmacology.
[30] H. Hägerström,et al. Rheological studies of the gelation of deacetylated gellan gum (Gelrite) in physiological conditions. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[31] M. B. Shields,et al. A dose-response study of piloplex for duration of action. , 1985, American journal of ophthalmology.
[32] O. Lorenzetti,et al. Ocular bioavailability of ciprofloxacin in sustained release formulations. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[33] M. Wirth,et al. Lectin-mediated drug delivery: fundamentals and perspectives , 2003 .
[34] Clive G. Wilson,et al. Ocular contact time of a carbomer gel (GelTears) in humans , 1998, The British journal of ophthalmology.
[35] Claus-Michael Lehr,et al. Bioadhesive Drug Delivery Systems : Fundamentals, Novel Approaches, and Development , 1999 .
[36] C. Allaire,et al. Ocular hypotensive efficacy and safety of once daily carteolol alginate , 2001, British Journal of Ophthalmology.
[37] S. P. Srinivas,et al. Use of fluorometry in assessing the efficacy of a cation-sensitive gel as an ophthalmic vehicle: comparison with scintigraphy. , 1992, Journal of pharmaceutical sciences.
[38] A. Solomon,et al. The effect of a new tear substitute containing glycerol and hyaluronate on keratoconjunctivitis sicca. , 1998, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[39] P. Sado,et al. Effect of cyclosporine A formulations on bovine corneal absorption: ex-vivo study. , 1997, Journal of microencapsulation.
[40] R. Pignatello,et al. Ocular tolerability of Eudragit RS100 and RL100 nanosuspensions as carriers for ophthalmic controlled drug delivery. , 2002, Journal of pharmaceutical sciences.
[41] M. Alonso,et al. Effect of lysozyme on the stability of polyester nanocapsules and nanoparticles: stabilization approaches. , 1997, Biomaterials.
[42] O. El-Gazayerly,et al. Preparation and evaluation of acetazolamide liposomes as an ocular delivery system , 1997 .
[43] S Tsukahara,et al. Structure and composition of rat precorneal tear film. A study by an in vivo cryofixation. , 1997, Investigative ophthalmology & visual science.
[44] S. Burgalassi,et al. Xyloglucan as a novel vehicle for timolol: pharmacokinetics and pressure lowering activity in rabbits. , 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[45] G. Smistad,et al. Bioadhesion of hydrated chitosans: An in vitro and in vivo study , 1996 .
[46] A. Bernkop‐Schnürch,et al. Polymers with Thiol Groups: A New Generation of Mucoadhesive Polymers? , 1999, Pharmaceutical Research.
[47] K. Carraway,et al. Detection of sialomucin complex (MUC4) in human ocular surface epithelium and tear fluid. , 2000, Investigative ophthalmology & visual science.
[48] L. Wilson,et al. Corneal contact times of ophthalmic vehicles. Evaluation by microscintigraphy. , 1975, Archives of ophthalmology.
[49] R. Gurny,et al. Biomaterials in ophthalmic drug delivery , 1996 .
[50] D. Craig,et al. An investigation into the rheological, dielectric and mucoadhesive properties of poly(acrylic acid) gel systems , 1995 .
[51] R. Gurny,et al. Bioerodible polymers for ocular drug delivery. , 1998, Critical reviews in therapeutic drug carrier systems.
[52] M. Fresta,et al. Characterization and In‐vivo Ocular Absorption of Liposome‐encapsulated Acyclovir , 1999, The Journal of pharmacy and pharmacology.
[53] S. Yalkowsky,et al. Formulation and in vivo evaluation of ocular insert containing phenylephrine and tropicamide. , 1999, International journal of pharmaceutics.
[54] Claus-Michael Lehr,et al. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers , 1992 .
[55] S. Mortazavi,et al. Factors Influencing Gel‐strengthening at the Mucoadhesive‐mucus Interface , 1994, The Journal of pharmacy and pharmacology.
[56] N. J. Van Haeringen,et al. Clinical biochemistry of tears , 1981 .
[57] A. Ludwig,et al. The use of xanthan gum in an ophthalmic liquid dosage form: rheological characterization of the interaction with mucin. , 2002, Journal of pharmaceutical sciences.
[58] H. Taylor,et al. The epidemiology of dry eye in Melbourne, Australia , 1998 .
[59] K. Tsubota,et al. Sodium hyaluronate eyedrops in the treatment of dry eyes. , 1995, The British journal of ophthalmology.
[60] John W. Shell. Ophthalmic drug delivery systems , 1984 .
[61] J. Kreuter,et al. Hydrocortisone delivery to healthy and inflamed eyes using a micellar polysorbate 80 solution or albumin nanoparticles , 1994 .
[62] A. Urtti,et al. Methylprednisolone esters of hyaluronic acid in ophthalmic drug delivery: in vitro and in vivo release studies , 1992 .
[63] M. Berry,et al. Commensal ocular bacteria degrade mucins , 2002, The British journal of ophthalmology.
[64] Robert Gurny,et al. Gamma scintigraphic study of precorneal drainage and assessment of miotic response in rabbits of various ophthalmic formulations containing pilocarpine , 1993 .
[65] Y. Zambito,et al. A study of release mechanisms of different ophthalmic drugs from erodible ocular inserts based on poly(ethylene oxide). , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[66] H. Sasaki,et al. Delivery of drugs to the eye by topical application , 1996, Progress in Retinal and Eye Research.
[67] R. Gurny,et al. Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations. , 1997, Pharmaceutica acta Helvetiae.
[68] A. Bernkop‐Schnürch,et al. In vitro evaluation of the permeation-enhancing effect of thiolated polycarbophil. , 2000, Journal of pharmaceutical sciences.
[69] D. Woodward,et al. Studies on the ocular pharmacology of prostaglandin D2. , 1990, Investigative ophthalmology & visual science.
[70] A. Bernkop‐Schnürch,et al. Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[71] R. Gurny,et al. Long-acting soluble bioadhesive ophthalmic drug insert (BODI) containing gentamicin for veterinary use: optimization and clinical investigation , 1995 .
[72] I. Gipson,et al. MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope. , 2003, Investigative ophthalmology & visual science.
[73] A S Hoffman,et al. An AB block copolymer of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugs. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[74] S. Burgalassi,et al. Development of a Simple Dry Eye Model in the Albino Rabbit and Evaluation of Some Tear Substitutes , 1999, Ophthalmic Research.
[75] J. Liaw,et al. In vivo gene delivery into ocular tissues by eye drops of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles , 2001, Gene Therapy.
[76] R. Gurny,et al. Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers. , 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[77] J. Jumblatt,et al. MUC7 Expression in the Human Lacrimal Gland and Conjunctiva , 2003, Cornea.
[78] M. Ohji,et al. Conjunctival epithelial cell hypermitosis and goblet cell hyperplasia in atopic keratoconjunctivitis. , 1993, American journal of ophthalmology.
[79] M. F. Saettone,et al. The validity of rabbits for investigations on ophthalmic vehicles: a comparison of four different vehicles containing tropicamide in humans and rabbits. , 1982, Pharmaceutica acta Helvetiae.
[80] R. Gurny,et al. Chitosan as tear substitute: a wetting agent endowed with antimicrobial efficacy. , 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[81] P. Furrer,et al. Étude comparative de la tolérance oculaire de 3 spécialités à base de timolol : influence du conservateur sur la tolérance oculaire , 2001 .
[82] A. Bron,et al. Physical properties of stimulated and unstimulated tears. , 1999, Experimental eye research.
[83] L. P. Aristoteli,et al. Isolation of conjunctival mucin and differential interaction with Pseudomonas aeruginosa strains of varied pathogenic potential. , 2003, Experimental Eye Research.
[84] Hormone replacement therapy and dry eye syndrome. , 2001 .
[85] L. Nielsen,et al. Bioadhesive drug delivery systems: I. Characterisation of mucoadhesive properties of systems based on glyceryl mono-oleate and glyceryl monolinoleate , 1998 .
[86] A. Sharma,et al. Mechanism of Tear Film Rupture and Formation of Dry Spots on Cornea , 1985 .
[87] I. Gipson,et al. The role of calcium in mucin packaging within goblet cells. , 2003, Experimental eye research.
[88] T. Fujihara,et al. P2Y(2) receptor elicits PAS-positive glycoprotein secretion from rabbit conjunctival goblet cells in vivo. , 2003, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[89] P. Sado,et al. Ophthalmic drug delivery systems—Recent advances , 1998, Progress in Retinal and Eye Research.
[90] J. Robinson,et al. Bioadhesive and phase-change polymers for ocular drug delivery , 1995 .
[91] R. Huupponen,et al. Macromolecular ionic complexes of cyclopentolate for topical ocular administration. Preparation and preliminary evaluation in albino rabbits , 1992 .
[92] P. Dilly. On the nature and the role of the subsurface vesicles in the outer epithelial cells of the conjunctiva. , 1985, The British journal of ophthalmology.
[93] J. Tiffany,et al. Tears in health and disease , 2003, Eye.
[94] S. H. Leung,et al. The contribution of anionic polymer structural features to mucoadhesion , 1987 .
[95] J. Blanchard,et al. Evaluation of pluronic F127-based sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model. , 1998, Journal of pharmaceutical sciences.
[96] A. Mitra,et al. Mucoadhesive polymers in ocular drug delivery , 1993 .
[97] G. Spedalieri,et al. Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. , 2002, Biomaterials.
[98] K. Kashiwagi,et al. Comparison of Efficacy and Tolerability between Two Gel-Forming Timolol Maleate Ophthalmic Solutions in Patients with Glaucoma or Ocular Hypertension , 2003, Ophthalmologica.
[99] A. Filippelli,et al. Effects of Timolol and of Timolol with Tamarind Seed Polysaccharide on Intraocular Pressure in Rabbits , 1999 .
[100] Y. Kawashima,et al. Effect of collagen cross-linking in collagen corneal shields on ocular drug delivery. , 1997, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[101] K. Tsubota. Tear dynamics and dry eye , 1998, Progress in Retinal and Eye Research.
[102] P. Amin,et al. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[103] A. Corfield,et al. Secreted human conjunctival mucus contains MUC5AC glycoforms. , 1999, Glycobiology.
[104] K. Tsubota,et al. Important concepts for treating ocular surface and tear disorders. , 1997, American journal of ophthalmology.
[105] V. H. Lee,et al. Topical ocular drug delivery: recent developments and future challenges. , 1986, Journal of ocular pharmacology.
[106] D. Meisner,et al. Liposome ocular delivery systems , 1995 .
[107] Robert Gurny,et al. PATENT LITERATURE REVIEW OF OPHTHALMIC INSERTS , 1995 .
[108] M Paulsson,et al. Controlled drug release from gels using surfactant aggregates: I. Effect of lipophilic interactions for a series of uncharged substances. , 2001, Journal of pharmaceutical sciences.
[109] T. Laurent. Biochemistry of hyaluronan. , 1987, Acta oto-laryngologica. Supplementum.
[110] D. Korb,et al. Histochemical analysis of secretory vesicles in nongoblet conjunctival epithelial cells , 1985, Acta ophthalmologica.
[111] J. Robinson,et al. Ocular delivery of progesterone using a bioadhesive polymer , 1985 .
[112] M. F. Saettone,et al. Vehicle effects on ophthalmic bioavailability: the influence of different polymers on the activity of pilocarpine in rabbit and man , 1982, The Journal of pharmacy and pharmacology.
[113] F. Paulsen,et al. Animal model for the absorption of lipophilic substances from tear fluid by the epithelium of the nasolacrimal ducts. , 2002, Investigative ophthalmology & visual science.
[114] C. Sébastian,et al. A new long acting ophthalmic formulation of carteolol containing alginic acid. , 2000, International journal of pharmaceutics.
[115] I. Gipson,et al. Characteristics of a glycoprotein in the ocular surface glycocalyx. , 1992, Investigative ophthalmology & visual science.
[116] Jeong-Sook Park,et al. rhEGF/HP-β-CD complex in poloxamer gel for ophthalmic delivery , 2002 .
[117] J. Remon,et al. Characterization and in vivo evaluation of ocular bioadhesive minitablets compressed at different forces. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[118] E. Lobel,et al. A novel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye , 1997 .
[119] Giovanni Puglisi,et al. Enhanced Ocular Anti-Inflammatory Activity of Ibuprofen Carried by an Eudragit RS100® Nanoparticle Suspension , 2002, Ophthalmic Research.
[120] Yang Li,et al. Characterization of Human Ocular Mucin Secretion Mediated by 15(S)-HETE , 2002, Cornea.
[121] L. Salminen,et al. Ocular inserts for topical delivery , 1995 .
[122] R. Craster,et al. Analysis of tear film rupture: effect of non-Newtonian rheology. , 2003, Journal of colloid and interface science.
[123] Ashutosh Sharma,et al. The role of lipid abnormalities, aqueous and mucus deficiencies in the tear film breakup, and implications for tear substitutes and contact lens tolerance , 1986 .
[124] J. Jumblatt,et al. MUC5AC mucin is a component of the human precorneal tear film. , 1999, Investigative ophthalmology & visual science.
[125] S. Burgalassi,et al. Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide). , 2002, International journal of pharmaceutics.
[126] J. Remon,et al. Evaluation of a mucoadhesive tablet for ocular use. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[127] R. Cavalli,et al. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. , 2002, International journal of pharmaceutics.
[128] F. Campbell,et al. Study of human precorneal tear film thickness and structure using laser interferometry. , 1992, Investigative ophthalmology & visual science.
[129] S. Rossi,et al. Characterization of chitosan hydrochloride--mucin rheological interaction: influence of polymer concentration and polymer:mucin weight ratio. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[130] D. Attwood,et al. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride. , 2001, International journal of pharmaceutics.
[131] M. Boehnke,et al. Influences of methylcellulose on corneal epithelial wound healing. , 1999, Journal of Ocular Pharmacology and Therapeutics.
[132] G. Cavallaro,et al. Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir. , 2001, Journal of pharmaceutical sciences.
[133] M. Miles,et al. Atomic force microscopy of the submolecular architecture of hydrated ocular mucins. , 1999, Biophysical journal.
[134] Lisbeth Illum,et al. Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2) , 1994, Pharmaceutical Research.
[135] G. Banchelli,et al. A New Viscosity Enhancer for Ophthalmic Preparations Devoid of Toxicity for Human Conjunctival Cells , 2000 .
[136] P. Sado,et al. New Ophthalmic Drug Delivery Systems , 1995 .
[137] J. Romanet,et al. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study]. , 2003, Journal francais d'ophtalmologie.
[138] N. Loya,et al. The effect of sodium hyaluronate on the corneal epithelium. An ultrastructural study. , 1988, Investigative ophthalmology & visual science.
[139] L. Silver,et al. Long-term intraocular pressure-lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with Timoptic XE 0.5% in a 12-month study. , 2000, American journal of ophthalmology.
[140] S. Leucuţa,et al. The kinetics of in vitro release and the pharmacokinetics of miotic response in rabbits of gelatin and albumin microspheres with pilocarpine , 1989 .
[141] C. Koller,et al. Propriétés et intérêt pharmaceutique des gels thermoréversibles à base de poloxamers et poloxamines , 1987 .
[142] K. Edsman,et al. Controlled drug release from gels using lipophilic interactions of charged substances with surfactants and polymers. , 2002, Journal of colloid and interface science.
[143] M. Calonge. The treatment of dry eye. , 2001, Survey of ophthalmology.
[144] M. F. Saettone,et al. Solubilization of tropicamide by poloxamers: physicochemical data and activity data in rabbits and humans , 1988 .
[145] I. Gipson,et al. Mucin gene expression is not regulated by estrogen and/or progesterone in the ocular surface epithelia of mice. , 2003, Experimental eye research.
[146] C. Dawson,et al. Demonstration of the mucous layer of the tear film by electron microscopy. , 1985, Investigative ophthalmology & visual science.
[147] Tomi Järvinen,et al. Ocular absorption following topical delivery , 1995 .
[148] E. Rosenlund. The intraocular pressure lowering effect of timolol in gel-forming solution. , 2009, Acta ophthalmologica Scandinavica.
[149] A. Rozier,et al. Gelrite®: A novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol , 1989 .
[150] S. Mortazavi,et al. An investigation into the role of water movement and mucus gel dehydration in mucoadhesion , 1993 .
[151] N. Peppas,et al. Enhanced hydrogel adhesion by polymer interdiffusion: use of linear poly(ethylene glycol) as an adhesion promoter. , 1997, Journal of biomaterials science. Polymer edition.
[152] J. C. Robinson. Ocular anatomy and physiology relevant to ocular drug delivery , 1993 .
[153] C. Camras,et al. Efficacy and Adverse Effects of Medications Used in the Treatment of Glaucoma , 1999, Drugs & aging.
[154] C. Baudouin,et al. Retentissement conjonctival des conservateurs : étude comparative de collyres bêta-bloquants conservés et non conservés chez des patients glaucomateux , 2003 .
[155] Hong-Ru Lin,et al. Carbopol/pluronic phase change solutions for ophthalmic drug delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[156] J. Friend,et al. Goblet cell density in ocular surface disease. A better indicator than tear mucin. , 1983, Archives of ophthalmology.
[157] L. Balant,et al. Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infections. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[158] M D Donovan,et al. Drug transfer through mucus. , 2001, Advanced drug delivery reviews.
[159] G. Banchelli,et al. Effect of Xyfoglucan (Tamarind Seed Polysaccharide) on Conjunctival Cell Adhesion to Laminin and on Corneal Epithelium Wound Healing , 2000, European journal of ophthalmology.
[160] C. Chiang,et al. Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[161] C. Bucolo,et al. Pharmacological Evaluation of a New Timolol/Pilocarpine Formulation , 1998, Ophthalmic Research.
[162] Robert Gurny,et al. Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants. , 2000, International journal of pharmaceutics.
[163] I. Gipson,et al. Vitamin A deficiency alters the expression of mucin genes by the rat ocular surface epithelium. , 2000, Investigative ophthalmology & visual science.
[164] C. Baudouin,et al. Évaluation de la cytotoxicité de trois substituts lacrymaux utilisés dans le traitement des syndromes secs , 2000 .
[165] M. Alonso,et al. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. , 2001, International journal of pharmaceutics.
[166] S. Burgalassi,et al. Gel-forming erodible inserts for ocular controlled delivery of ofloxacin. , 2001, International journal of pharmaceutics.
[167] K. Himmelstein,et al. Modification of in situ gelling behavior of carbopol solutions by hydroxypropyl methylcellulose. , 1995, Journal of pharmaceutical sciences.
[168] I. Kellaway,et al. Influence of molecular weight and formulation pH on the precorneal clearance rate of hyaluronic acid in the rabbit eye , 1995 .
[169] P. Perugini,et al. Bioadhesive Microspheres for Ophthalmic Administration of Acyclovir , 1997, The Journal of pharmacy and pharmacology.
[170] J. Kreuter,et al. Evaluation of pilocarpine-loaded albumin particles as controlled drug delivery systems for the eye. II. Co-administration with bioadhesive and viscous polymers , 1995 .
[171] Clive G. Wilson,et al. Treatment of diseases of the eye with mucoadhesive delivery systems , 1993 .
[172] A. Bernkop‐Schnürch,et al. Improvement in the in situ gelling properties of deacetylated gellan gum by the immobilization of thiol groups. , 2003, Journal of pharmaceutical sciences.
[173] K. Swan. USE OF METHYL CELLULOSE IN OPHTHALMOLOGY , 1945 .
[174] S. Engström,et al. In vitro release of timolol maleate from an in situ gelling polymer system , 1993 .
[175] W. Jagla,et al. Secretory peptides TFF1 and TFF3 synthesized in human conjunctival goblet cells. , 1999, Investigative ophthalmology & visual science.
[176] C. Radke,et al. Deposition and Thinning of the Human Tear Film , 1996, Journal of colloid and interface science.
[177] M. F. Saettone,et al. Polymer effects on ocular bioavailability: the influence of different liquid vehicles on the mydriatic response of tropicamide in humans and in rabbits , 1984 .
[178] R. Herrero-Vanrell,et al. Enhancement of the mydriatic response to tropicamide by bioadhesive polymers. , 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[179] A. Corfield,et al. Membrane-associated mucins in normal human conjunctiva. , 2000, Investigative ophthalmology & visual science.
[180] I. Kaur,et al. Penetration Enhancers and Ocular Bioadhesives: Two New Avenues for Ophthalmic Drug Delivery , 2002, Drug development and industrial pharmacy.
[181] M. Alonso,et al. The potential of chitosan in ocular drug delivery , 2003, The Journal of pharmacy and pharmacology.
[182] J. Robinson,et al. Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes. , 1976, Journal of pharmaceutical sciences.
[183] W. Osborne,et al. Mucous granule exocytosis and CFTR expression in gallbladder epithelium. , 2000, Glycobiology.
[184] I. Kellaway,et al. Precorneal Clearance of Mucoadhesive Microspheres from the Rabbit Eye , 1995, The Journal of pharmacy and pharmacology.
[185] J. Robinson,et al. Distribution of poly-hexyl-2-cyano-[3-14C]acrylate nanoparticles in healthy and chronically inflamed rabbit eyes , 1989 .
[186] P. Lama. Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment. , 2002, American journal of ophthalmology.
[187] Robert Gurny,et al. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. , 1999, International journal of pharmaceutics.
[188] A. Joshi. Microparticulates for ophthalmic drug delivery. , 1994, Journal of ocular pharmacology.
[189] V. H. Lee,et al. Improved ocular penetration of gentamicin by mucoadhesive polymer polycarbophil in the pigmented rabbit. , 1994, Investigative ophthalmology & visual science.
[190] A. Rozier,et al. Functionality testing of gellan gum, a polymeric excipient material for ophthalmic dosage forms , 1997 .
[191] A. Zimmer,et al. Studies on the transport pathway of PBCA nanoparticles in ocular tissues. , 1991, Journal of microencapsulation.
[192] D. K. Majumdar,et al. Ketorolac entrapped in polymeric micelles: preparation, characterisation and ocular anti-inflammatory studies. , 2000, International journal of pharmaceutics.
[193] A. Mitra,et al. Ophthalmic Drug Delivery Systems , 2003 .
[194] N. Yüksel,et al. The influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infants. , 2009, Acta ophthalmologica Scandinavica.
[195] A. Bernkop‐Schnürch,et al. Thiolated polymers--thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates. , 2001, Biomaterials.
[196] G. Snibson,et al. Ocular Surface Residence Times of Artificial Tear Solutions , 1992, Cornea.
[197] I. Gipson,et al. Alteration of mucin in human conjunctival epithelia in dry eye. , 1998, Investigative ophthalmology & visual science.
[198] P. Couvreur,et al. Comparison of the ocular distribution of a model oligonucleotide after topical instillation in rabbits of conventional and new dosage forms. , 1998, Journal of drug targeting.
[199] I. Gipson,et al. Alteration in goblet cell numbers and mucin gene expression in a mouse model of allergic conjunctivitis. , 2001, Investigative ophthalmology & visual science.
[200] T. Inatomi,et al. Expression of secretory mucin genes by human conjunctival epithelia. , 1996, Investigative ophthalmology & visual science.
[201] N. Fullwood,et al. Tight junction-related protein expression and distribution in human corneal epithelium. , 2003, Experimental eye research.
[202] D. Krohn,et al. Lectin-mediated attachment of liposomes to cornea: influence on transcorneal drug flux. , 1982, Investigative ophthalmology & visual science.
[203] P. Chetoni,et al. Ocular mini-tablets for controlled release of timolol: evaluation in rabbits. , 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[204] A. Bernkop‐Schnürch,et al. The Role of Glutathione in the Permeation Enhancing Effect of Thiolated Polymers , 2002, Pharmaceutical Research.
[205] A. Hoffman,et al. Mucoadhesive drug carriers based on complexes of poly(acrylic acid) and PEGylated drugs having hydrolysable PEG-anhydride-drug linkages. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[206] A. Ludwig,et al. A comparative rheological study on carbopol viscous solutions and, the evaluation of their suitability as the ophthalmic vehicles and artificial tears. , 1992, Pharmaceutica acta Helvetiae.
[207] J. Siepmann,et al. PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[208] A Shedden,et al. Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: a six-month, double-masked, multicenter study. , 2001, Clinical therapeutics.
[209] J. Jumblatt,et al. Regulation of ocular mucin secretion by P2Y2 nucleotide receptors in rabbit and human conjunctiva. , 1998, Experimental eye research.
[210] M. Oechsner,et al. Polyacrylic acid/polyvinylpyrrolidone bipolymeric systems. I. Rheological and mucoadhesive properties of formulations potentially useful for the treatment of dry-eye-syndrome. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[211] U Conte,et al. Pectin microspheres as ophthalmic carriers for piroxicam: evaluation in vitro and in vivo in albino rabbits. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[212] J. Smart,et al. A rheological assessment of the nature of interactions between mucoadhesive polymers and a homogenised mucus gel. , 1998, Biomaterials.
[213] F. Holly,et al. Formation and rupture of the tear film. , 1973, Experimental eye research.
[214] S. Kawakami,et al. Controlled release and ocular absorption of tilisolol utilizing ophthalmic insert-incorporated lipophilic prodrugs. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[215] A. Bernkop‐Schnürch,et al. Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[216] M. Ooteghem. Factors Influencing the Retention of Ophthalmic Solutions on the Eye Surface , 1987 .
[217] G. Milazzo,et al. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye , 2002, The British journal of ophthalmology.
[218] J. Robinson,et al. Ocular evaluation of methylcellulose vehicle in albino rabbits. , 1974, Journal of pharmaceutical sciences.
[219] J D Smart,et al. A rheological examination of the mucoadhesive/mucus interaction: the effect of mucoadhesive type and concentration. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[220] J. Carlfors,et al. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[221] I. Kellaway,et al. An investigation of the interfacial interaction between poly(acrylic acid) and glycoprotein , 1998 .
[222] I. Gipson,et al. Epithelial mucins of the ocular surface: structure, biosynthesis and function. , 2001, Experimental eye research.
[223] K. Langer,et al. Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery: Part III: Evaluation as drug delivery system for ophthalmic applications , 1997 .
[224] D. Monti,et al. Muco-Adhesive Liquid Ophthalmic Vehicles - Evaluation of Macromolecular Ionic Complexes of Pilocarpine , 1989 .
[225] D. Worthen,et al. An evaluation of the pilocarpine Ocusert. , 1974, Investigative ophthalmology.
[226] A. El-Kamel. In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. , 2002, International journal of pharmaceutics.
[227] V. H. Lee,et al. Influence of Preparation Conditions on Acyclovir-Loaded Poly-d,l-Lactic Acid Nanospheres and Effect of PEG Coating on Ocular Drug Bioavailability , 2003, Pharmaceutical Research.
[228] J. Blanchard,et al. Pluronic F127-based ocular delivery system containing biodegradable polyisobutylcyanoacrylate nanocapsules of pilocarpine. , 2000, Drug delivery.
[229] J. Carlfors,et al. Rheological evaluation of Gelrite in situ gels for ophthalmic use. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[230] A. Bernkop‐Schnürch,et al. Evidence for the interpenetration of mucoadhesive polymers into the mucous gel layer , 2003 .
[231] J. Gallo,et al. A Simple Rheological Method for the in Vitro Assessment of Mucin-Polymer Bioadhesive Bond Strength , 1990, Pharmaceutical Research.
[232] R. Prescott,et al. Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome , 1999, The British journal of ophthalmology.
[233] S. Rossi,et al. Characterization of rheological and mucoadhesive properties of three grades of chitosan hydrochloride. , 1997, Farmaco.
[234] J P Gilbard,et al. Human Tear Film Electrolyte Concentrations in Health and Dry-Eye Disease , 1994, International ophthalmology clinics.
[235] H. Struck,et al. Comparison of 0.1% dexamethasone phosphate eye gel (Dexagel) and 1% prednisolone acetate eye suspension in the treatment of post-operative inflammation after cataract surgery , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.
[236] Naseem A. Charoo,et al. Ophthalmic Delivery of Ciprofloxacin Hydrochloride from Different Polymer Formulations: In Vitro and In Vivo Studies , 2003, Drug development and industrial pharmacy.
[237] R. Gurny,et al. Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI) for the treatment of external ocular infections in dogs. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[238] Shulin Ding. RECENT DEVELOPMENTS IN OPHTHALMIC DRUG DELIVERY , 1998 .
[239] H. Kaş. Chitosan: properties, preparations and application to microparticulate systems. , 1997, Journal of microencapsulation.
[240] P. Giunchedi,et al. Albumin Microspheres for Ocular Delivery of Piroxicam , 2000 .
[241] R. Gurny,et al. Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogels , 1995 .
[242] Deshpande,et al. Ocular drug delivery in veterinary medicine. , 1997, Advanced drug delivery reviews.
[243] F. Paulsen,et al. The cavernous body of the human efferent tear ducts contributes to regulation of tear outflow. , 2003, Investigative ophthalmology & visual science.
[244] P. Chetoni,et al. Silicone rubber/hydrogel composite ophthalmic inserts: preparation and preliminary in vitro/in vivo evaluation. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[245] R. Gorla,et al. Nonlinear theory of tear film rupture. , 2000, Journal of Biomechanical Engineering.
[246] J. Tiffany,et al. Components responsible for the surface tension of human tears. , 1999, Current eye research.
[247] Susan C. Miller,et al. Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits , 1982 .
[248] J. Robinson,et al. Bioadhesive-based dosage forms: the next generation. , 2000, Journal of pharmaceutical sciences.
[249] D. Rogers,et al. Lectins in ocular drug delivery: An investigation of lectin binding sites on the corneal and conjunctival surfaces , 1996 .
[250] S. Burgalassi,et al. Relevance of polymer molecular weight to the in vitro/in vivo performances of ocular inserts based on poly(ethylene oxide). , 2001, International journal of pharmaceutics.
[251] Ruxandra Gref,et al. The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[252] Robert Gurny,et al. Design and evaluation of controlled release systems for the eye , 1987 .
[253] A. Topalkara,et al. Adverse effects of topical antiglaucoma drugs on the ocular surface , 2000, Clinical & experimental ophthalmology.
[254] R. Hodges,et al. Presence of nerves and their receptors in mouse and human conjunctival goblet cells. , 2001, Investigative ophthalmology & visual science.
[255] S. Burgalassi,et al. Pharmacokinetics and anti-inflammatory activity in rabbits of a novel indomethacin ophthalmic solution. , 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[256] A. Bernkop‐Schnürch,et al. Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[257] S. Dinslage,et al. A comparative bioavailability study of three conventional eye drops versus a single lyophilisate , 2003, The British journal of ophthalmology.
[258] Y. Tsai,et al. The Preparation of Norfloxacin‐loaded Liposomes and their In‐vitro Evaluation in Pig's Eye , 1996, The Journal of pharmacy and pharmacology.
[259] P Buri,et al. Chitosan: a unique polysaccharide for drug delivery. , 1998, Drug development and industrial pharmacy.
[260] A. Ludwig,et al. Optimisation of carbomer viscous eye drops: an in vitro experimental design approach using rheological techniques. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[261] H. Taylor,et al. Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome. , 1997, Ophthalmology.
[262] A. Bernkop‐Schnürch,et al. In vitro evaluation of the permeation enhancing effect of polycarbophil-cysteine conjugates on the cornea of rabbits. , 2002, Journal of pharmaceutical sciences.
[263] J. Pintor,et al. Nucleotides and dinucleotides in ocular physiology: New possibilities of nucleotides as therapeutic agents in the eye , 2003 .
[264] R. Gurny,et al. Concept and development of ophthalmic pseudo-latexes triggered by pH , 1991 .
[265] P. Eustace,et al. Polyacrylic Acid Gel in Patients with Dry Eyes: A Randomised Comparison with Polyvinyl Alcohol , 1998, European journal of ophthalmology.
[266] H Lennernäs,et al. Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[267] T. Inatomi,et al. Mucin genes expressed by the ocular surface Epithelium , 1997, Progress in Retinal and Eye Research.
[268] J. Kreuter. Particulates (Nanoparticles and Microparticles) , 1993 .
[269] J. Greaves,et al. Polymers and the precorneal tear film , 1992 .
[270] E. Topp,et al. Gellan-based systems for ophthalmic sustained delivery of methylprednisolone , 1993 .
[271] H. Junginger,et al. Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo. , 2001, Journal of pharmaceutical sciences.
[272] A. Tomlinson,et al. Effect of oral contraceptives on tear physiology , 2001, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.
[273] J. Hardy,et al. A comparison of the effect of viscosity on the precorneal residence of solutions in rabbit and man , 1986, The Journal of pharmacy and pharmacology.
[274] P. Couvreur,et al. Characterization of a new ocular delivery system based on a dispersion of liposomes in a thermosensitive gel , 1998 .
[275] A. Ludwig,et al. Influence of viscolysers on the residence of ophthalmic solutions evaluated by slit lamp fluorophotometry , 1992 .
[276] S. Klyce,et al. Determination of tear volume and tear flow. , 1966, Investigative ophthalmology.
[277] L. Carney,et al. Relationship between goblet cell density and tear function tests , 2003, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.
[278] J. Hadgraft,et al. Evaluation of Mucoadhesive Polymers in Ocular Drug Delivery. II. Polymer-Coated Vesicles , 1992, Pharmaceutical Research.
[279] C. Cho,et al. Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro. , 2003, International journal of pharmaceutics.
[280] Robert Gurny,et al. Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods. , 2003, International journal of pharmaceutics.
[281] D. Meller,et al. Oxidative reactions in the tear fluid of patients suffering from dry eyes , 1995, Graefe's Archive for Clinical and Experimental Ophthalmology.
[282] M. Alonso,et al. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers , 1997 .
[283] T. Inatomi,et al. Human corneal and conjunctival epithelia express MUC1 mucin. , 1995, Investigative ophthalmology & visual science.
[284] W. C. Stewart,et al. Efficacy and Safety of Timolol Solution Once Daily versus Timolol Gel in Treating Elevated Intraocular Pressure , 1998, Journal of glaucoma.
[285] B. Yerxa. Therapeutic use of nucleotides in respiratory and ophthalmic diseases , 2001 .
[286] S. Hsu,et al. Preparation of controlled release ophthalmic drops, for glaucoma therapy using thermosensitive poly-N-isopropylacrylamide. , 2002, Biomaterials.
[287] C. Baudouin,et al. Cytoprotective effects of hyaluronic acid and Carbomer 934P in ocular surface epithelial cells. , 2002, Investigative ophthalmology & visual science.
[288] J. Murube,et al. Origin and Types of Emotional Tearing , 1999, European journal of ophthalmology.
[289] Y. Ogura,et al. Biodegradable Polymers for Ocular Drug Delivery , 2001, Ophthalmologica.
[290] S. Keipert,et al. Physico-chemical, in vitro and in vivo characterisation of polymers for ocular use. , 2000, Die Pharmazie.
[291] L. P. Aristoteli,et al. Adhesion of Pseudomonas aeruginosa ocular isolates to mucin , 2001, Clinical & experimental ophthalmology.
[292] H. Brewitt. Tränenersatzmittel - Experimentelle und klinische Beobachtungen , 1988 .
[293] A. Ludwig,et al. Evaluation of sodium hyaluronate as viscous vehicle for eye drops. , 1989, Journal de pharmacie de Belgique.
[294] Zhenghe Xu,et al. Physical characterization of a chitosan-based hydrogel delivery system. , 2002, Journal of pharmaceutical sciences.
[295] R. Gurny,et al. Evaluation of soluble Bioadhesive Ophthalmic Drug Inserts (BODI) for prolonged release of gentamicin: lachrymal pharmacokinetics and ocular tolerance. , 1998, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[296] E. Rask-Pedersen,et al. Viscous carbomer eye drops in patients with dry eyes. Efficacy and safety. A randomized, open, cross-over, multicentre study. , 2009, Acta ophthalmologica Scandinavica.
[297] M. F. Saettone,et al. Polymer effects on ocular bioavailability. II. The influence of benzalkonium chloride on the mydriatic response of tropicamide in different polymeric vehicles , 1985 .
[298] A. Bernkop‐Schnürch,et al. Synthesis and characterisation of mucoadhesive thiolated polymers. , 2000, International journal of pharmaceutics.
[299] I. Gipson,et al. C57BL/6 mice lacking Muc1 show no ocular surface phenotype. , 2000, Investigative Ophthalmology and Visual Science.
[300] I. Kellaway,et al. Pilocarpine bioavailability from a mucoadhesive liposomal ophthalmic drug delivery system , 1992 .
[301] C. Baudouin. Side effects of antiglaucomatous drugs on the ocular surface. , 1996, Current opinion in ophthalmology.
[302] K. Langer,et al. Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery: Part II: arecaidine propargyl ester and pilocarpine loading and in vitro release , 1997 .
[303] J. Carlfors,et al. Rheological evaluation and ocular contact time of some carbomer gels for ophthalmic use , 1996 .
[304] H E Kaufman,et al. The instilled fluid dynamics and surface chemistry of polymers in the preocular tear film. , 1975, Investigative ophthalmology.
[305] G. Forstner. Signal transduction, packaging and secretion of mucins. , 1995, Annual review of physiology.
[306] A. Bernkop‐Schnürch,et al. Development of controlled drug release systems based on thiolated polymers. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[307] K. Tsubota,et al. Hydroxypropyl Methylcellulose for the Treatment of Severe Dry Eye Associated with Sjogren's Syndrome , 1996, Cornea.
[308] S. Tsukahara,et al. Histochemical study on rat tear film and ocular surface epithelial cells , 1998 .
[309] W. Mathers,et al. Model for Ocular Tear Film Function , 1996, Cornea.
[310] A. Bernkop‐Schnürch,et al. Mucoadhesive and cohesive properties of poly(acrylic acid)-cysteine conjugates with regard to their molecular mass. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[311] J. Diamond,et al. Systemic Adverse Effects of Topical Ophthalmic Agents , 1997, Drugs & aging.